一分钟看懂
这是一项关于非小细胞肺癌的III 期研究，登记的药物或干预包括Atezolizumab，当前状态为研究进行中，已停止招募。登记地点显示中国北京、长沙、重庆、福州等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Atezolizumab · III 期
登记条件中文摘要
年龄范围：18岁及以上
登记的基本范围为不限性别，年龄18岁及以上；以下仅摘录8项专业入选条件，需结合英文原文并由研究团队确认。
登记记录列出8项主要排除条件，具体医学含义需结合英文原文并由研究团队确认。
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Beijing Tiantan Hospital,Capital Medical University · 北京
- Xuanwu Hospital, Capital Medical University · 北京
- Beijing Chest Hospital · 北京
- The Third Xiangya Hospital Of Central South University · 长沙
- Daping Hospital of Third Military Medical University · 重庆
- Fujian Cancer Hospital · 福州
- Sir Run Run Shaw Hospital Zhejiang University · 杭州
- Anhui Province Cancer Hospital · 合肥
- The First Affiliated Hospital of Anhui Medical University · 合肥
- Linyishi Cancer Hospital · 临沂
- Nanjing Chest Hospital · 南京
- Shanghai Chest Hospital · 上海
- Cancer Hospital of Shantou University Medical College · 汕头
- Tianjin Medical University General Hospital · 天津
- Tianjin Cancer Hospital · 天津
- Tumor Center,Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · 武汉
- Renmin Hospital of Wuhan University · 武汉
- The First Affiliated Hospital of Xiamen University · 厦门
入选条件原文摘录
以下为摘录，请打开原始登记查看完整入排标准。
- * ECOG performance status of 0 or 1.
- * Histologically or cytologically confirmed, Stage IV non-squamous or squamous NSCLC.
- * No prior treatment for Stage IV non-squamous or squamous NSCLC.
- * Patients who have received prior neo-adjuvant, adjuvant chemotherapy, radiotherapy, or chemo-radiotherapy with curative intent for non-metastatic disease must have experienced a treatment free interval of at least 6 months from enrollment since the last chemotherapy, radiotherapy, or chemo-radiotherapy cycle.
- * Tumor TC3 or IC3, as determined by SP142 performed by a central laboratory on previously obtained archival tumor tissue or tissue obtained from a biopsy at screening.
- * Measurable disease, as defined by RECIST v1.1.
- * Adequate hematologic and end-organ function.
- * Life expectancy ≥3 months.
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT05047250；登记信息更新于 2026-09-30；本站同步于 2026-10-08，中国中心当前名额未经人工确认。